Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
Zhidi He(Chinese Academy of Sciences), Yongzhuo Huang(Chinese Academy of Sciences)
Cited by 39
Related Papers
Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
|Chemical Science|2018|248
Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery
|Theranostics|2018|212
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
|Journal for ImmunoTherapy of Cancer|2020|134
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy
|Acta Pharmacologica Sinica|2017|111
Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery
|Journal of Experimental & Clinical Cancer Research|2023|70